IL6 and neoplasm: Consistent with the critical role of endothelial IL-6 in mouse survival, EC-specific knockout of IL-6 significantly reduced tumor growth, as indicated by a 70% decrease in average tumor volume (at day 12 after tumor implantation, Fig. 8b).